PRESENTATION AND CHARACTERIZATION OF CARBENICILLIN RESISTANCE FACTOR IN PSEUDOMONAS-AERUGINOSA

被引：0
|
作者：
JOUVENOT, M
MICHELBRIAND, Y
机构：
来源：
ANNALES DE MICROBIOLOGIE | 1975年 / B126卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：414 / 414
页数：1
相关论文
共 50 条
  • [1] CARBENICILLIN RESISTANCE OF PSEUDOMONAS-AERUGINOSA
    RODRIGUEZTEBAR, A
    ROJO, F
    DAMASO, D
    VAZQUEZ, D
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (02) : 255 - 261
  • [2] NATURE OF CARBENICILLIN RESISTANCE IN PSEUDOMONAS-AERUGINOSA
    THOMAS, AH
    BROADBRIDGE, RA
    JOURNAL OF GENERAL MICROBIOLOGY, 1972, 70 (APR): : 231 - +
  • [3] TRANSFERABLE CARBENICILLIN RESISTANCE IN PSEUDOMONAS-AERUGINOSA
    AYLIFFE, GAJ
    ROE, E
    LOWBURY, EJL
    NATURE-NEW BIOLOGY, 1972, 235 (57): : 141 - &
  • [4] TRANSMISSIBLE CARBENICILLIN RESISTANCE FACTOR FROM A STRAIN OF PSEUDOMONAS-AERUGINOSA
    MICHELBRIAND, Y
    JOUVENOT, M
    COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE D, 1975, 280 (20): : 2397 - 2400
  • [5] TRANSFERABLE RESISTANCE TO CARBENICILLIN AND GENTAMICIN IN PSEUDOMONAS-AERUGINOSA
    VANRENSBURG, AJ
    SOUTH AFRICAN MEDICAL JOURNAL, 1974, 48 (28): : 1185 - 1186
  • [6] FREQUENCY OF TRANSMISSIBLE RESISTANCE TO CARBENICILLIN IN PSEUDOMONAS-AERUGINOSA
    MICHELBRIAND, Y
    LAPORTE, JM
    THERAPIE, 1978, 33 (04): : 527 - 527
  • [7] CARBENICILLIN R FACTOR FROM PSEUDOMONAS-AERUGINOSA
    VANRENSBURG, AJ
    DEKOCK, MJ
    SOUTH AFRICAN MEDICAL JOURNAL, 1974, 48 (28): : 1187 - 1190
  • [8] SUSCEPTIBILITY OF PSEUDOMONAS-AERUGINOSA TO CARBENICILLIN
    TRAUB, WH
    RAYMOND, EA
    APPLIED MICROBIOLOGY, 1970, 20 (04) : 630 - &
  • [9] RPL11, AN R FACTOR OF PSEUDOMONAS-AERUGINOSA DETERMINING CARBENICILLIN AND GENTAMICIN RESISTANCE
    KORFHAGEN, TR
    LOPER, JC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 7 (01) : 69 - 73
  • [10] EFFECT OF OXACILLIN ON THE DEVELOPMENT OF RESISTANCE OF PSEUDOMONAS-AERUGINOSA AGAINST CARBENICILLIN
    SCHORCHER, HA
    PETERSEN, KF
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1979, 29-1 (05): : 744 - 747
12345